: Cargo Therapeutics rises 2.2% in trading debut after IPO priced at low end of range

The stock of Cargo Therapeutics, a clinical-stage biotech, rose in its trading debut Friday.

Previous post Outside the Box: Why a prenup could be the right prescription to keep a blended family healthy
Next post Retirement Weekly: How to use TIPS to build up retirement wealth